Thomas HE - Search Results

1

Monitoring immunomodulation strategies in type 1 diabetes.

Krishnamurthy B, Lacorcia M, Kay TWH, Thomas HE, Mannering SI. Krishnamurthy B, et al. Among authors: thomas he. Front Immunol. 2023 Jun 6;14:1206874. doi: 10.3389/fimmu.2023.1206874. eCollection 2023. Front Immunol. 2023. PMID: 37346035 Free PMC article. Review.

2

RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.

Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J. Kay TW, et al. Among authors: thomas he. J Immunol. 1996 Oct 15;157(8):3688-93. J Immunol. 1996. PMID: 8871671

3

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.

French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM. French MB, et al. Among authors: thomas he. Diabetes. 1997 Jan;46(1):34-9. doi: 10.2337/diab.46.1.34. Diabetes. 1997. PMID: 8971078

4

Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.

Stephens LA, Thomas HE, Kay TW. Stephens LA, et al. Among authors: thomas he. J Autoimmun. 1997 Jun;10(3):293-8. doi: 10.1006/jaut.1997.0133. J Autoimmun. 1997. PMID: 9218757

5

Interferon regulatory factor 1 is induced by interferon-gamma equally in neurons and glial cells.

Thomas HE, Dutton R, Bartlett PF, Kay TW. Thomas HE, et al. J Neuroimmunol. 1997 Sep;78(1-2):132-7. doi: 10.1016/s0165-5728(97)00091-x. J Neuroimmunol. 1997. PMID: 9307237

6

CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse.

Kay TW, Chaplin HL, Parker JL, Stephens LA, Thomas HE. Kay TW, et al. Among authors: thomas he. Res Immunol. 1997 Jun;148(5):320-7. doi: 10.1016/s0923-2494(97)87241-0. Res Immunol. 1997. PMID: 9352596 Review. No abstract available.

7

IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

Thomas HE, Parker JL, Schreiber RD, Kay TW. Thomas HE, et al. J Clin Invest. 1998 Sep 15;102(6):1249-57. doi: 10.1172/JCI2899. J Clin Invest. 1998. PMID: 9739059 Free PMC article.

8

Tumor necrosis factor-alpha-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic beta cells.

Stephens LA, Thomas HE, Ming L, Grell M, Darwiche R, Volodin L, Kay TW. Stephens LA, et al. Among authors: thomas he. Endocrinology. 1999 Jul;140(7):3219-27. doi: 10.1210/endo.140.7.6873. Endocrinology. 1999. PMID: 10385418

9

Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.

Thomas HE, Darwiche R, Corbett JA, Kay TW. Thomas HE, et al. J Immunol. 1999 Aug 1;163(3):1562-9. J Immunol. 1999. PMID: 10415060

10

Transgenic overexpression of human Bcl-2 in islet beta cells inhibits apoptosis but does not prevent autoimmune destruction.

Allison J, Thomas H, Beck D, Brady JL, Lew AM, Elefanty A, Kosaka H, Kay TW, Huang DC, Strasser A. Allison J, et al. Int Immunol. 2000 Jan;12(1):9-17. doi: 10.1093/intimm/12.1.9. Int Immunol. 2000. PMID: 10607745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters